Quality Cancer Care Alliance

Reducing Cancer Costs Through Symptom Management and Triage Pathways.

Barkley R1, Soobader MJ2, Wang J2, Blau S3, Page RD4.https://www.ncbi.nlm.nih.gov/pubmed/30576262

What Is Data Science: Addressing the Uncertainty Behind Addressing Uncertainty

https://www.journalofclinicalpathways.com/commentary/what-data-science-addressing-uncertainty-behind-addressing-uncertainty

Artificial intelligence (AI) to improve patient outcomes in community oncology practices.

https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e18098

Empower Physicians to Fight Financial Toxicity With Biosimilars

Author: Kathy Oubre, MS https://www.ajmc.com/journals/evidence-based-oncology/2019/december-2019/empower-physicians-to-fight-financial-toxicity-with-biosimilars

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.

Slamon DJ1, Neven P1, Chia S1, Fasching PA1, De Laurentiis M1, Im SA1, Petrakova K1, Val Bianchi G1, Esteva FJ1, Martín M1, Nusch A1, Sonke GS1, De la Cruz-Merino L1, Beck JT1, Pivot X1, Sondhi M1, Wang Y1, Chakravartty A1, Rodriguez-Lorenc K1, Taran T1, Jerusalem…

Dr. Robin Zon, Medical Oncologist and President of Michiana Hematology Oncology, A member of the QCCA Network, discusses how her practice uses data as leverage for providing quality cancer care.

https://youtu.be/kV5BFnwWf2A

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study.

Piha-Paul SA1, Taylor MH2, Spitz D3, Schwartzberg L4, Beck JT5, Bauer TM6, Meric-Bernstam F1, Purkayastha D7, Karpiak L7, Szpakowski S8, Braiteh F9 https://www.ncbi.nlm.nih.gov/pubmed/31741715